German Pharmaceuticals & Biotech High Growth Potential Companies

Cantourage Group

Market Cap: €57.2m

Operates as a medical cannabis company in Europe.

SynBiotic

Market Cap: €21.2m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Evotec

Market Cap: €950.4m

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Apontis Pharma

Market Cap: €92.9m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Formycon

Market Cap: €382.3m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

PharmaSGP Holding

Market Cap: €292.6m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Bayer

Market Cap: €19.8b

Operates as a life science company worldwide.